Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTS-HF: Finerenone vs Eplerenone in Worsening Chronic Heart Failure
NCT01807221Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 2 trial of finerenone in heart failure (HF), sponsored by Bayer. Started Jun 2013; status: completed.
02
Drugs
finerenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01807221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01807221.